Welcome to the 4th Process Development for Cell Therapies Summit
Driving Process Robustness, Scalability, Speed & Affordability
The cell therapy landscape is rapidly evolving, driven by technological advancements, a surge in late-stage programs, and increasing cost pressures. As therapies become more complex and regulatory demands rise, there is an urgent need for refined process development strategies to accelerate the delivery of consistent, cost-effective therapies to patients.
Join the 4th Process Development for Cell Therapies Summit to hear from 24+ industry leaders from biopharma and service providers as they share best practices for driving process robustness, scalability, speed, and affordability. Gain insights into how to develop consistent, scalable, and cost-effective solutions for both autologous and allogeneic cell therapies.
Engage with 100+ process development specialists and professionals from MSAT, QC, and CMC to address the most pressing PD bottlenecks and streamline the transition from early to late-stage development. Gain technical and strategic insights to enhance scalability and ensure regulatory readiness, helping you position your therapy for long-term commercial success.
Explore the latest innovations from Galapagos, Takeda, Cellectis, and Arsenal Bio as they share real-world case studies on transformative tools and technologies, including automated closed-system manufacturing, workflow digitization, and artificial intelligence.
BRAND-NEW PROGRAM FOR 2025
Our World-Class Speaker Faculty Includes:
Amanda Medcalf Conerty
Executive Director, Manufacturing, Advocacy & Engagement
Artiva Biotherapeutics, Inc
Previously Attending Companies Include:
What Your Peers Have to Say:
"It's high time that Process Development professionals come together and share key ideas and insights so that the entire industry can advance based on the achievements of these skilled individuals."
– 2025 Speaker, Senior Engineer, TG Therapeutics
"Unlike many events that focus solely on breakthrough tech, this one addressed the practical realities of scaling and reproducibility—giving valuable insight into both shared and modality-specific challenges in cell therapy.”
– 2024 Attendee, Senior Engineer, Arsenal Bio
“It was great to connect with other process development professionals and realize that many of the optimizations and challenges we’ve faced are shared across the industry.”
– 2024 Speaker, Senior Scientist, Immatics
Proud To Partner With:
Lead Partner:
Expertise Partner:
Expertise Partner:
Exhibition Partner:
Hosting Partner:
